
Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
Description
About Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
The Human Cytomegalovirus (HCMV) (strain AD169) Envelope glycoprotein B Peptide (IEDB: 10961) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Envelope glycoprotein Peptide, H-DYSNTHSTRYV-OH (Uniprot: P06473 aa: 217-227) from JPT is produced under strict quality control and quality management.
Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV - Specifications
- Peptide sequence: H-DYSNTHSTRYV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
References:
Read References with JPT’s Antigen Peptides
Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV has been described in:
Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H., Eur J Immunol, 2004 (PMID: 15368271)
Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium., PLoS Pathog, 2016 (PMID: 27606804)
GDP-l-fucose synthase is a CD4<sup>+</sup> T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis., Sci Transl Med, 2018 (PMID: 30305453)
Documentation
Documentation for Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
Properties
Properties of Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Human Cytomegalovirus (HCMV) |
Protein Name: | Envelope glycoprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV
Information | Values |
---|---|
Sequence: | H-DYSNTHSTRYV-OH |
Specifications: | 11mer peptide as TFA salt |